Investor presentation
No summary for this filing – the full text is below.
Select text to share a quote on X · sign in to keep highlights & notes in your FAB notes
Fusion Antibodies plc (AIM: FAB), specialists in pre-clinical antibody discovery, engineering and supply for both therapeutic drug and diagnostic applications, announces that management will be presenting at the Shard Capital Partners LLP's Investor Evening on Tuesday, 24 September 2024.
The event is scheduled to take place at 25 Eccleston Place London SW1W 9NF, London at 17:30. Investors can register to attend the in-person event via completing the attendance form here.
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.